Cargando…
“Omics” in traumatic brain injury: novel approaches to a complex disease
BACKGROUND: To date, there is neither any pharmacological treatment with efficacy in traumatic brain injury (TBI) nor any method to halt the disease progress. This is due to an incomplete understanding of the vast complexity of the biological cascades and failure to appreciate the diversity of secon...
Autores principales: | Abu Hamdeh, Sami, Tenovuo, Olli, Peul, Wilco, Marklund, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357753/ https://www.ncbi.nlm.nih.gov/pubmed/34273044 http://dx.doi.org/10.1007/s00701-021-04928-7 |
Ejemplares similares
-
Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis
por: van Gent, Jort A. N., et al.
Publicado: (2019) -
Functional outcome, in-hospital healthcare consumption and in-hospital costs for hospitalised traumatic brain injury patients: a Dutch prospective multicentre study
por: van Dijck, Jeroen T. J. M., et al.
Publicado: (2020) -
Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study
por: van Essen, Thomas A., et al.
Publicado: (2018) -
Association of the bleeding time test with aspects of traumatic brain injury in patients with alcohol use disorder
por: Tsitsopoulos, P. P., et al.
Publicado: (2020) -
Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury
por: Tsitsopoulos, Parmenion P., et al.
Publicado: (2017)